MX2022014356A - Ciertas composiciones quimicas y metodos de uso de las mismas. - Google Patents
Ciertas composiciones quimicas y metodos de uso de las mismas.Info
- Publication number
- MX2022014356A MX2022014356A MX2022014356A MX2022014356A MX2022014356A MX 2022014356 A MX2022014356 A MX 2022014356A MX 2022014356 A MX2022014356 A MX 2022014356A MX 2022014356 A MX2022014356 A MX 2022014356A MX 2022014356 A MX2022014356 A MX 2022014356A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- chemical compositions
- certain chemical
- disorder
- disease
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 6
- 201000010099 disease Diseases 0.000 abstract 3
- 102100024457 Cyclin-dependent kinase 9 Human genes 0.000 abstract 2
- 101000980930 Homo sapiens Cyclin-dependent kinase 9 Proteins 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000007270 liver cancer Diseases 0.000 abstract 1
- 208000014018 liver neoplasm Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063025474P | 2020-05-15 | 2020-05-15 | |
| PCT/US2021/032495 WO2021231892A1 (en) | 2020-05-15 | 2021-05-14 | Certain chemical compositions and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022014356A true MX2022014356A (es) | 2023-03-09 |
Family
ID=76270111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022014356A MX2022014356A (es) | 2020-05-15 | 2021-05-14 | Ciertas composiciones quimicas y metodos de uso de las mismas. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11591322B2 (https=) |
| EP (1) | EP4149941B1 (https=) |
| JP (1) | JP2023526332A (https=) |
| KR (1) | KR20230051127A (https=) |
| CN (1) | CN116261561B (https=) |
| AU (1) | AU2021273072A1 (https=) |
| BR (1) | BR112022023199A2 (https=) |
| CA (1) | CA3178813A1 (https=) |
| ES (1) | ES3054109T3 (https=) |
| IL (1) | IL298219A (https=) |
| MX (1) | MX2022014356A (https=) |
| WO (1) | WO2021231892A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3054109T3 (en) | 2020-05-15 | 2026-01-29 | Algen Biotechnologies Inc | Certain chemical compositions and methods of use thereof |
| WO2023086417A1 (en) * | 2021-11-11 | 2023-05-19 | Algen Biotechnologies, Inc. | Compounds and methods of use thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4932412A (en) | 1986-12-18 | 1990-06-12 | Immunomedics, Inc. | Intraoperative and endoscopic tumor detection and therapy |
| EP1223952B1 (en) | 1999-10-07 | 2008-04-16 | Carlos Estuardo Aguilar-Cordova | Methods for treatment of solid tumors and metastasis by gene therapy |
| WO2004110350A2 (en) | 2003-05-14 | 2004-12-23 | Torreypines Therapeutics, Inc. | Compouds and uses thereof in modulating amyloid beta |
| WO2006071958A1 (en) | 2004-12-29 | 2006-07-06 | Millennium Pharmaceuticals, Inc. | Compounds useful as chemokine receptor antagonists |
| US8415381B2 (en) | 2009-07-30 | 2013-04-09 | Novartis Ag | Heteroaryl compounds and their uses |
| WO2012101065A2 (en) * | 2011-01-28 | 2012-08-02 | Novartis Ag | Pyrimidine biaryl amine compounds and their uses |
| WO2012101063A1 (en) * | 2011-01-28 | 2012-08-02 | Novartis Ag | N-acyl pyridine biaryl compounds and their uses |
| CN103339110A (zh) * | 2011-01-28 | 2013-10-02 | 诺瓦提斯公司 | 作为cdk9抑制剂的取代的杂-联芳基化合物及其用途 |
| WO2012101066A1 (en) | 2011-01-28 | 2012-08-02 | Novartis Ag | Pyridine biaryl amine compounds and their uses |
| US9013997B2 (en) | 2012-06-01 | 2015-04-21 | Broadcom Corporation | System for performing distributed data cut-through |
| EP3126525B1 (en) | 2014-04-04 | 2020-02-19 | Memorial Sloan-Kettering Cancer Center | Method and kits for identifying of cdk9 inhibitors for the treatment of cancer |
| NZ734082A (en) | 2015-01-20 | 2019-01-25 | Boehringer Ingelheim Animal Health Usa Inc | Anthelmintic compounds, compositions and method of using thereof |
| PL3429591T3 (pl) | 2016-03-16 | 2023-07-17 | Kura Oncology, Inc. | Podstawione pochodne tieno[2,3-d]pirymidyny jako inhibitory meniny-mll i metody ich zastosowania |
| EP3874045A4 (en) | 2018-10-31 | 2022-09-07 | The Regents of The University of California | Methods and kits for identifying cancer treatment targets |
| CN114025772A (zh) | 2019-04-24 | 2022-02-08 | 纪念斯隆凯特琳癌症中心 | 用于治疗ras突变体癌症的组合物和方法 |
| JP7677914B2 (ja) | 2019-06-21 | 2025-05-15 | アルゲン バイオテクノロジーズ，インク． | 標的遺伝子を特定するための方法およびシステム |
| EP4126918A4 (en) | 2020-03-31 | 2024-05-29 | The Regents of the University of California | COMPOSITIONS AND METHODS FOR IDENTIFYING HOST CELL TARGET PROTEINS FOR THE TREATMENT OF RNA VIRUS INFECTIONS |
| ES3054109T3 (en) | 2020-05-15 | 2026-01-29 | Algen Biotechnologies Inc | Certain chemical compositions and methods of use thereof |
| EP4185867A4 (en) | 2020-07-22 | 2024-08-07 | Algen Biotechnologies, Inc. | Methods and systems for determining drug effectiveness |
| WO2023086417A1 (en) | 2021-11-11 | 2023-05-19 | Algen Biotechnologies, Inc. | Compounds and methods of use thereof |
-
2021
- 2021-05-14 ES ES21730069T patent/ES3054109T3/es active Active
- 2021-05-14 KR KR1020227043684A patent/KR20230051127A/ko active Pending
- 2021-05-14 BR BR112022023199A patent/BR112022023199A2/pt unknown
- 2021-05-14 IL IL298219A patent/IL298219A/en unknown
- 2021-05-14 EP EP21730069.8A patent/EP4149941B1/en active Active
- 2021-05-14 AU AU2021273072A patent/AU2021273072A1/en active Pending
- 2021-05-14 CN CN202180059974.5A patent/CN116261561B/zh active Active
- 2021-05-14 JP JP2022569528A patent/JP2023526332A/ja active Pending
- 2021-05-14 CA CA3178813A patent/CA3178813A1/en active Pending
- 2021-05-14 WO PCT/US2021/032495 patent/WO2021231892A1/en not_active Ceased
- 2021-05-14 MX MX2022014356A patent/MX2022014356A/es unknown
-
2022
- 2022-04-28 US US17/731,943 patent/US11591322B2/en active Active
-
2023
- 2023-01-17 US US18/097,782 patent/US12264152B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN116261561A (zh) | 2023-06-13 |
| US20220289725A1 (en) | 2022-09-15 |
| US20230295135A1 (en) | 2023-09-21 |
| EP4149941A1 (en) | 2023-03-22 |
| CA3178813A1 (en) | 2021-11-18 |
| US12264152B2 (en) | 2025-04-01 |
| AU2021273072A1 (en) | 2022-12-15 |
| BR112022023199A2 (pt) | 2023-04-04 |
| KR20230051127A (ko) | 2023-04-17 |
| ES3054109T3 (en) | 2026-01-29 |
| IL298219A (en) | 2023-01-01 |
| US11591322B2 (en) | 2023-02-28 |
| CN116261561B (zh) | 2025-10-31 |
| JP2023526332A (ja) | 2023-06-21 |
| WO2021231892A1 (en) | 2021-11-18 |
| EP4149941B1 (en) | 2025-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202190630A1 (ru) | Способы комбинированной терапии | |
| MX2023007212A (es) | Formulaciones de pulverizacion de epinefrina. | |
| MX2021008610A (es) | Tratamiento del cancer usando combinaciones de inhibidores de erk y raf. | |
| EA201790195A1 (ru) | Способы лечения рака с применением ингибиторов tigit и противораковых агентов | |
| MX2019002750A (es) | Derivados de pirazolopiridina como moduladores de cinasa 1 progenitora hematopoyetica (hpk1) y usos de los mismos para tratamiento de cancer. | |
| EA202192122A1 (ru) | Соединения, обладающие активностью индуцирования ферроптоза, и способы их применения | |
| CY1111565T1 (el) | Θεραπεια συνδυασμου του zd6474 με 5-fu και/ή cpt-11 | |
| MX391720B (es) | Terapia combinada para tratar cáncer. | |
| NO20054988D0 (no) | Preparater og metoder for behandling av cancer | |
| EA201391286A1 (ru) | Лечение солидных опухолей | |
| MX2020009773A (es) | Terapia de combinacion. | |
| NI200800169A (es) | Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento del dolor | |
| BR112015026247A2 (pt) | métodos para o tratamento de câncer com o uso de terapia combinada com inibidor de cinase tor | |
| MX390121B (es) | Combinaciones de un inhibidor de btk y un inhibidor de pi3k para tratar neoplasias malignas hematológicas. | |
| EA202090741A1 (ru) | Конъюгаты антитела к тканевому фактору и лекарственного средства и их применение в лечении рака | |
| ZA202304965B (en) | Combination therapy for treating cancer | |
| MX2022014356A (es) | Ciertas composiciones quimicas y metodos de uso de las mismas. | |
| PH12019500758A1 (en) | Pharmaceutical compositions and methods for the treatment of cancer | |
| BR112022026247A2 (pt) | Método para aumentar a eficácia terapêutica de um agente de imunoterapia, método de tratamento de câncer e método de inibição do crescimento de uma célula de câncer | |
| CO2022000266A2 (es) | Inhibidores de enzimas | |
| MX2021013901A (es) | Composiciones y métodos para el tratamiento del cáncer. | |
| MX2024003918A (es) | Agente terapeutico que induce citotoxicidad para usarse en terapia del cancer. | |
| EA201001853A1 (ru) | Фармацевтическая комбинация | |
| MX2021009051A (es) | Tratamiento de lesiones cutaneas y prurito en pacientes con prurigo nodular. | |
| MX2024005220A (es) | Endoxifeno para el tratamiento del cancer. |